Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders

ClinicalTrials.gov ID: NCT00055653

Public ClinicalTrials.gov record NCT00055653. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 4:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Unrelated Umbilical Cord Blood As An Alternate Source Of Stem Cells Transplantation

Study identification

NCT ID
NCT00055653
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Roswell Park Cancer Institute
Other
Enrollment
Not listed

Conditions and interventions

Interventions

  • anti-thymocyte globulin Biological
  • filgrastim Biological
  • busulfan Drug
  • cyclophosphamide Drug
  • cyclosporine Drug
  • fludarabine phosphate Drug
  • melphalan Drug
  • methylprednisolone Drug
  • umbilical cord blood transplantation Procedure
  • radiation therapy Radiation

Biological · Drug · Procedure + 1 more

Eligibility (public fields only)

Age range
Up to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2002
Primary completion
Aug 31, 2003
Completion
Aug 31, 2005
Last update posted
Mar 6, 2011

2003 – 2005

United States locations

U.S. sites
25
U.S. states
16
U.S. cities
23
Facility City State ZIP Site status
City of Hope Comprehensive Cancer Center Duarte California 91010-3000
Children's Hospital Los Angeles Los Angeles California 90027-0700
Jonsson Comprehensive Cancer Center, UCLA Los Angeles California 90095-1781
Children's Hospital of Orange County Orange California 92868
Children's Medical Center, University of California San Francisco San Francisco California 94143-1278
Children's National Medical Center Washington D.C. District of Columbia 20010-2970
Indiana University Cancer Center Indianapolis Indiana 46202-5289
Children's Hospital of New Orleans New Orleans Louisiana 70118
Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston Massachusetts 02115
Spectrum Health and DeVos Children's Hospital Grand Rapids Michigan 49503
University of Minnesota Cancer Center Minneapolis Minnesota 55455
Children's Mercy Hospital Kansas City Missouri 64108
Cardinal Glennon Children's Hospital St Louis Missouri 63104-1095
Hackensack University Medical Center Hackensack New Jersey 07601
Roswell Park Cancer Institute Buffalo New York 14263-0001
North Shore University Hospital Manhasset New York 11030
James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester New York 14642
Duke Comprehensive Cancer Center Durham North Carolina 27710
Ireland Cancer Center Cleveland Ohio 44106-5065
Children's Hospital of Pittsburgh Pittsburgh Pennsylvania 15213
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232-6310
Medical City Dallas Hospital Dallas Texas 75230
Children's Medical Center of Dallas Dallas Texas 75235
Texas Transplant Institute San Antonio Texas 78229
Fred Hutchinson Cancer Research Center Seattle Washington 98109-1024

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00055653, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 6, 2011 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00055653 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →